Jeffrey Weber Explains Organ-Specific Side Effects of Checkpoint Inhibitors
Dr. Jeffrey Weber describes the organ-specific side effects that can occur in a patient on checkpoint inhibitors.
Jeffrey Weber on the Role of Oncology Nurses in Treating Patients With Checkpoint Inhibitors
Jeffrey Weber, MD, PhD, deputy director of the Perlmutter Cancer Center, NYU Langone Medical Center, discusses the role of the oncology nurse when treating patients who have cancer with checkpoint inhibitors.
Olanzapine Significantly Reduces CINV in Patients Receiving MEC
Reimagining Frailty Screenings in Head and Neck Cancer
Screening for Pain and Depression is Not Enough in Cancer Care
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC
2 Clarke Drive Cranbury, NJ 08512